HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy.

Abstract
Epithelial cancer cells are likely to undergo epithelial-mesenchymal transition (EMT) prior to entering the peripheral circulation. By undergoing EMT, circulating tumor cells (CTCs) lose epithelial markers and may escape detection by conventional methods. Therefore, we conducted a pilot study to investigate mRNA transcripts of EMT-inducing transcription factors (TFs) in tumor cells from the peripheral blood (PB) of patients with primary breast cancer (PBC). PB mononuclear cells were isolated from 52 patients with stages I-III PBC and 30 healthy donors (HDs) and were sequentially depleted of EpCAM(+) cells and CD45(+) leukocytes, henceforth referred to as CD45(-). The expression levels of EMT-inducing TFs (TWIST1, SNAIL1, SLUG, ZEB1 and FOXC2) in the CD45(-) cells were determined using quantitative real-time polymerase chain reaction. The highest level of expression by the CD45(-) cell fraction of HD was used as "cutoff" to determine if samples from patients with PBC overexpressed any EMT-inducing TFs. In total, 15.4% of patients with PBC overexpressed at least one of the EMT-inducing TF transcripts. Overexpression of any EMT-inducing TF transcripts was more likely to be detected in patients with PBC who received neoadjuvant therapies (NAT) than patients who received no NAT (p = 0.003). Concurrently, CTCs were detected in 7 of 38 (18.4%) patients by CellSearch® and in 15 of 42 (35.7%) patients by AdnaTest™. There was no association between the presence of CTCs measured by CellSearch® or AdnaTest™. In summary, our results demonstrate that CTCs with EMT phenotype may occur in the peripheral circulation of patients with PBC and that NAT is unable to eliminate CTCs undergoing EMT.
AuthorsMichal Mego, Sendurai A Mani, Bang-Ning Lee, Changping Li, Kurt W Evans, Evan N Cohen, Hui Gao, Summer A Jackson, Antonio Giordano, Gabriel N Hortobagyi, Massimo Cristofanilli, Anthony Lucci, James M Reuben
JournalInternational journal of cancer (Int J Cancer) Vol. 130 Issue 4 Pg. 808-16 (Feb 15 2012) ISSN: 1097-0215 [Electronic] United States
PMID21387303 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
CopyrightCopyright © 2011 UICC.
Chemical References
  • Forkhead Transcription Factors
  • Homeodomain Proteins
  • Nuclear Proteins
  • RNA, Messenger
  • SNAI1 protein, human
  • Snail Family Transcription Factors
  • TWIST1 protein, human
  • Transcription Factors
  • Twist-Related Protein 1
  • ZEB1 protein, human
  • Zinc Finger E-box-Binding Homeobox 1
  • mesenchyme fork head 1 protein
  • Leukocyte Common Antigens
  • PTPRC protein, human
Topics
  • Breast Neoplasms (metabolism, pathology, therapy)
  • Epithelial-Mesenchymal Transition
  • Female
  • Forkhead Transcription Factors (genetics)
  • Homeodomain Proteins (genetics)
  • Humans
  • Leukocyte Common Antigens (analysis)
  • Neoadjuvant Therapy
  • Neoplastic Cells, Circulating
  • Nuclear Proteins (genetics)
  • RNA, Messenger (analysis)
  • Snail Family Transcription Factors
  • Transcription Factors (genetics)
  • Twist-Related Protein 1 (genetics)
  • Zinc Finger E-box-Binding Homeobox 1

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: